Elan reintroduces Tysabri

Athlone-headquartered pharmaceutical giant Elan has announced the reintroduction for sale in the US and Europe of multiple sclerosis drug Tysabri.

Elan reintroduces Tysabri

Athlone-headquartered pharmaceutical giant Elan has announced the reintroduction for sale in the US and Europe of multiple sclerosis drug Tysabri.

In Europe, Tysabri has been launched in Germany, Ireland, the UK and Sweden.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited